MARETTI, ELEONORA
 Distribuzione geografica
Continente #
NA - Nord America 5.351
EU - Europa 2.957
AS - Asia 1.070
SA - Sud America 46
OC - Oceania 40
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 9.478
Nazione #
US - Stati Uniti d'America 5.312
GB - Regno Unito 915
IT - Italia 792
SE - Svezia 418
CN - Cina 344
SG - Singapore 310
DE - Germania 251
HK - Hong Kong 126
FR - Francia 120
UA - Ucraina 110
FI - Finlandia 80
TR - Turchia 78
IN - India 77
RU - Federazione Russa 71
BG - Bulgaria 59
BE - Belgio 47
BR - Brasile 39
CA - Canada 37
AU - Australia 31
ID - Indonesia 29
IR - Iran 20
LT - Lituania 18
JP - Giappone 17
KR - Corea 16
NL - Olanda 13
IE - Irlanda 12
MY - Malesia 9
NZ - Nuova Zelanda 9
PK - Pakistan 9
CH - Svizzera 7
CZ - Repubblica Ceca 7
EG - Egitto 6
IQ - Iraq 6
PH - Filippine 6
PL - Polonia 6
ES - Italia 5
PT - Portogallo 5
RO - Romania 5
VN - Vietnam 5
EU - Europa 4
HU - Ungheria 4
IL - Israele 4
RS - Serbia 4
TW - Taiwan 4
CL - Cile 3
TH - Thailandia 3
AT - Austria 2
BD - Bangladesh 2
DK - Danimarca 2
HR - Croazia 2
MX - Messico 2
PE - Perù 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AZ - Azerbaigian 1
CO - Colombia 1
JO - Giordania 1
KW - Kuwait 1
LV - Lettonia 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NO - Norvegia 1
ZA - Sudafrica 1
Totale 9.478
Città #
Santa Clara 772
Southend 721
Fairfield 570
Chandler 541
Woodbridge 356
Ashburn 340
Nyköping 257
Dearborn 240
Singapore 229
Ann Arbor 225
Houston 223
Wilmington 215
Jacksonville 204
Modena 185
Seattle 182
Cambridge 175
Hong Kong 123
Beijing 83
Princeton 62
Sofia 56
San Diego 54
Bremen 53
New York 52
Redwood City 51
Eugene 48
Helsinki 48
Fremont 43
Milan 43
Izmir 39
Frankfurt am Main 33
Ottawa 31
Moscow 30
Brussels 26
Shanghai 25
London 23
Rome 21
Jakarta 19
Falls Church 18
Bologna 17
Sydney 16
Parma 15
Nanjing 13
Napoli 13
Reggio Nell'emilia 13
Guangzhou 12
Gurgaon 11
Belfast 10
Los Angeles 10
Tulare 10
Boardman 9
Mumbai 9
Norwalk 9
San Mateo 9
Vailate 9
Formigine 8
Hangzhou 8
Munich 8
Pontinia 8
Torino 8
Centrale 7
Dublin 7
Hefei 7
Hyderabad 7
Kunming 7
New Delhi 7
Philadelphia 7
Seoul 7
Aiseau 6
College Park 6
Deford 6
Jinan 6
Manila 6
Mountain View 6
San Francisco 6
Segrate 6
Tokyo 6
Wuhan 6
Bomporto 5
Brno 5
Catania 5
Dong Ket 5
Ferrara 5
Gunzenhausen 5
Leawood 5
Porto Mantovano 5
Selvazzano Dentro 5
Xian 5
Belgrade 4
Cinisello Balsamo 4
El Paso 4
Florence 4
Hebei 4
Iowa City 4
Kanpur 4
Kochi 4
Kraków 4
Misterbianco 4
Naples 4
Rehovot 4
San Giuliano Milanese 4
Totale 6.859
Nome #
The Impact of Lipid Corona on Rifampicin Intramacrophagic Transport Using Inhaled Solid Lipid Nanoparticles Surface-Decorated with a Mannosylated Surfactant 334
Conveying a newly designed hydrophilic anti-human thymidylate synthase peptide to cisplatin resistant cancer cells: are pH-sensitive liposomes more effective than conventional ones? 273
Enhanced anti-hyperproliferative activity of human thymidylate synthase inhibitor peptide by solid lipid nanoparticle delivery 271
Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis 255
pH-Promoted Release of a Novel Anti-Tumour Peptide by “Stealth” Liposomes: Effect of Nanocarriers on the Drug Activity in Cis-Platinum Resistant Cancer Cells 241
Organo-modified bentonite for gentamicin topical application: interlayer structure and in vivo skin permeation 238
Gastroretentive montmorillonite-tetracycline nanoclay for the treatment of Helicobacter pylori infection 228
Characterization of natural clays from italian deposits with focus on elemental composition and exchange estimated by edx analysis: potential pharmaceutical and cosmetic uses 222
Surface engineering of Solid Lipid Nanoparticle assemblies by methyl α-d-mannopyranoside for the active targeting to macrophages in anti-tuberculosis inhalation therapy 219
Polymeric and Solid Lipid Nanoparticles for nose-to-brain delivery of geraniolursodeoxycholic acid conjugate: development and characterization studies 216
Application of the "in-oil nanoprecipitation" method in the encapsulation of hydrophilic drugs in PLGA nanoparticles 212
In vivo penetration of bare and lipid-coated silica nanoparticles across the human stratum corneum 204
Self-Assembled Lipid Nanoparticles for Oral Delivery of Heparin-Coated Iron Oxide Nanoparticles for Theranostic Purposes 204
A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells 204
Solid Lipid Nanoparticle assemblies (SLNas) for an anti-TB inhalation treatment-A Design of Experiments approach to investigate the influence of pre-freezing conditions on the powder respirability 199
In vivo silica nanoparticle translocation across human stratum corneum: the effect of surface hydrophobization in relation to hair follicle density. 194
Anti-TB inhalation therapy: Design of mannose-based functionalised Solid Lipid Microparticles for an active targeting to alveolar macrophages 191
pH sensitive PEGylated Liposomes delivering active hydrophilic peptide with anticancer activity: in vitro study on cDDP-resistant ovarian cell line 183
Self-assembled organogelators as artificial stratum corneum models: key-role parameters for skin permeation prediction 181
DEVELOPMENT AND COMPARISON OF TWO LIPID-BASED NANOSYSTEMS FOR THE CO-DELIVERY OF RIFAMPICIN AND ISONIAZID: SMALL-ANGLE NEUTRON SCATTERING CHARACTERISATION 174
Novel engineered lipid-based nanoparticles for pulmonary tuberculosis inhalation therapy 174
In vitro behaviour of hybrid lipid/chitosan nanoparticles for the oral delivery of heparin 173
SOLID LIPID MICROPARTICLES FOR INHALED ANTI-TB THERAPY BY DPI: INFLUENCE OF THE PRODUCTION PROCESS ON DRUG STABILITY AND POWDER BREATHABILITY 163
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery 163
Small-angle neutron scattering characterization of liposomes for anti-tuberculosis inhaled therapy. 162
Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy 161
Drugs/lamellae interface influences the inner structure of double-loaded liposomes for inhaled anti-TB therapy: An in-depth small-angle neutron scattering investigation 161
In Vivo Biodistribution of Respirable Solid Lipid Nanoparticles Surface-Decorated with a Mannose-Based Surfactant: A Promising Tool for Pulmonary Tuberculosis Treatment? 160
Self-assembling organogelators for artificial stratum corneum models: key-role parameters in skin permeation prediction 158
Lipid-based microparticles for TB inhaled therapy: physical properties and cell internalization 157
Nanoencapsulation of an hTS inhibitor octapeptide against ovarian cancer in solid lipid matrix 156
PROGETTAZIONE E OTTIMIZZAZIONE DI SISTEMI MICROPARTICELLARI PER LA VEICOLAZIONE AI MACROFAGI ALVEOLARI DI FARMACI ANTITUBERCOLARI PER VIA INALATORIA 151
Development of lipid nanocarriers as delivery systems for a small peptide with anti-ovarian activity 149
Metodo per modulare l'assorbimento fagocitario di un principio attivo o un suo precursore da parte di macrofagi 146
Formulazione per veicolare principi attivi lipofili 145
Inhaled SLM for anti-TB therapy by DPI device: process parameters affecting freeze-drying and breathability 142
Aerodynamic performance of lipid-based nanocarrier functionalized by novel mannose derivatives for Rifampicin intramacrophagic delivery 141
SURFACE ENGINEERING OF SOLID LIPID NANOASSEMBLIES FOR INHALED INTRAMACROPHAGIC ANTI-TB THERAPY 141
PASSIVE AND ACTIVE TARGETING TO MACROPHAGES USING LIPID NANOPARTICLES ASSEMBLIES FOR ANTI-TB THERAPY BY PULMONARY ROUTE 139
In vitro evaluation on CaCo-2 cells of hybrid lipid/chitosan nanoparticles for the oral delivery of heparin. 131
Development and in vitro characterization of SLN encapsulating magnetic Heparin coated Iron Oxide for theranostic application 130
Tetracycline-Montmorillonite nanoclay for the treatment of H. pylori infection 129
Inhaled micro- or nanoparticles: which are the best for intramacrophagic anti-infectious therapies? 127
Medicinal Chemistry drives drug targeted delivery: a successful interplay 121
The improvement of Solid Lipid Microparticle breathability for an anti-TB inhalation therapy 118
Inhalated drug delivery systems to target alveolar macrophages for tuberculosis therapy: design of safe SLM loaded with rifampicin 118
Chitosan/heparin polyelectrolyte complexes as ion-paring approach to encapsulate heparin in orally administrable SLN: In vitro evaluation 118
Solid Lipid Microparticles for inhaled anti-TB therapy by DPI: influence of the production process on drug stability and powder breathability 115
Nuove molecole funzionalizzanti per il targeting ai macrofagi di vettori lipidici 114
Design, Characterization, and In Vitro Assays on Muscle Cells of Endocannabinoid-like Molecule Loaded Lipid Nanoparticles for a Therapeutic Anti-Inflammatory Approach to Sarcopenia 111
Nasal administration of nanoencapsulated geraniol/ursodeoxycholic acid conjugate: Towards a new approach for the management of Parkinson's disease 110
Formulazione per veicolare principi attivi lipofili 98
Development of solid lipid nanoparticles for the delivery of an anti- inflammatory drug to muscle skeletal cells 98
In vivo β-carotene skin permeation modulated by Nanostructured Lipid Carriers 96
Nasal biocompatible powder of geraniol oil complexed with cyclodextrins for neurodegenerative diseases: Physicochemical characterization and in vivo evidences of nose to brain delivery 89
Design and physicochemical characterization of novel hybrid SLN-liposome nanocarriers for the smart co-delivery of two antitubercular drugs 88
Palmitoylethanolamide-loaded Solid Lipid Nanoparticles for a therapeutic anti-inflammatory approach of Sarcopenia involving ECS 66
Nanoparticulate systems for the delivery of Palmitoylethanolamide to muscle cells 57
Epitranscriptomics as a New Layer of Regulation of Gene Expression in Skeletal Muscle: Known Functions and Future Perspectives 53
Physicochemical characterization of SLN/Liposomes hybrid nanoparticles for the co-delivery of two antitubercular drugs: focus on SANS analysis 52
Inflammatory-Targeted Lipid Carrier as a New Nanomaterial to Formulate an Inhaled Drug Delivery System 41
Inhaled lipid nanoparticles: a feasible tool for a challenging route 35
Combination of Nanodelivery Systems and Constituents Derived from Novel Foods: A Comprehensive Review 30
Optimizing Formulation Conditions of PLGA Microparticles to Enhance Indomethacin Encapsulation 25
Linking endocannabinoid system, palmitoylethanolamide, and sarcopenia in view of therapeutic implications 9
Investigating hybrid lipid-PLGA nanoparticles loaded with an endogenous endocannabinoid-like molecule for targeting inflamed muscle 8
APPLICATION OF A NEW SURFACTANT FOR INHALED ANTI-INFLAMMATORY DRUG DELIVERY SYSTEMS: FROM NANOCARRIER TO PURE NANODRUG FORMULATION 7
IMMOBILIZATION OF HEPARIN BY TERNARY POLYELECTROLYTE COMPLEXES: A PRELIMINARY STUDY 5
Lipid Nanodrugs for topical anti-inflammatory treatment of psoriasis: in vivo studies 4
ENGINEERING OF DRUG DELIVERY SYSTEMS TO ENHANCE DRUG POTENTIAL: FROM BEADS TO POLYMER-FREE NANOPARTICLES 4
New insights on Indomethacin and PLGA interaction for a rational design of microparticles to be administered via intra-articular route 3
Nanoparticle-mediated delivery to skeletal muscle cells of N-palmitoylethanolamide (PEA), an endocannabinoid-like molecule with anti-inflammatory properties 2
Totale 9.697
Categoria #
all - tutte 34.217
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.217


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020960 0 0 0 0 0 218 240 154 130 67 91 60
2020/20211.574 227 143 108 105 131 85 113 129 97 246 138 52
2021/20221.308 33 77 119 59 55 123 50 88 180 120 276 128
2022/20231.475 222 205 105 172 162 171 29 143 148 24 59 35
2023/2024863 34 67 69 94 174 106 70 74 18 28 50 79
2024/20251.478 78 30 118 227 601 424 0 0 0 0 0 0
Totale 9.697